Aurinia Pharmaceuticals, Inc. (AUPH)
15.55
-0.11
(-0.70%)
USD |
NASDAQ |
Jun 09, 12:58
Aurinia Pharmaceuticals Market Cap : 2.033B for June 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| enGene Therapeutics, Inc. | 107.52M |
| Medicus Pharma Ltd. | 12.80M |
| Kiniksa Pharmaceuticals International Plc | 3.768B |
| Xenon Pharmaceuticals, Inc. | 4.964B |
| Psyence Biomedical Ltd. | 2.114M |
Market Cap Related Metrics
| PE Ratio | 7.187 |
| PS Ratio | 7.159 |
| PEG Ratio | 0.0105 |
| Price to Book Value | 3.582 |
| Price to Free Cash Flow | 12.79 |
| Price | 15.55 |
| Earnings Yield | 13.91% |
| PEGY Ratio | 0.0105 |
| Operating PE Ratio | 16.43 |
| Normalized PE Ratio | 7.185 |